Biovista has an ongoing R&D program to develop new and improve existing products and services. Research projects are carried out in-house or within international consortia in areas such as orphan diseases, personalized medicine, drug de-risking, opinion mining, systematic discovery support and linguistics.
Select a project from the list to find out more information on each.
Neurotoxicity De-Risking in Preclinical Drug Discovery
In this project Biovista with EFPIA members Sanofi, Novartis, MSD, Pfizer UCB Biopharma, AZ, Fujifilm Cellular Dynamics and a group of leading EU academic institutions, will work to identify novel mechanisms of neurotoxicity…more
Duchenne Muscular Dystrophy
In this collaboration, Biovista is working with DART Therapeutics Inc., to develop therapies for Duchenne Muscular Dystrophy (DMD)…more
Chronic Fatigue Syndrome
In this project Biovista is using its proprietary COSS™ Drug Repurposing platform to systematically identify non-obvious drug candidates to treat CFS… more
In this project Biovista is exploring the utility of patient data for the identification of new biomarkers and the prediction of clinical outcomes (drug risk profiles) in the area of oncology… more
Advancing Clinico Genomic Trials on Cancer
ACGT was a EU project in the space of information technologies (IT), in post genomic clinical trials, focusing as a starting point on cancer… more
Murine Models for Immunological Disease
Integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease (MUGEN)… more
Biovista’s goal with the Esperonto project was to support literature based scientific discovery in the domain of the life sciences… more
INNOVANET was a European Commission funded project on systematic innovation and scientific discovery. The project published a strategic roadmap on the ‘mechanizing’ of the process of scientific discovery and innovation, i.e. on what information and knowledge technologies are necessary to better support the innovation process… more
Ontoweb was a thematic network… more